| 779 |
lotenone
|
|
475: Binding of chemicals to ionotropic glutamate receptors leads to impairment of learning and memory via loss of drebrin from dendritic spines of neurons
|
| 780 |
Polychlorinated biphenyls; mixture of specific PCBs
|
-
Polychlorinated biphenyls; mixture of specific PCBs, CAS-RN: NOCAS, DTXSID0040591
|
504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level
|
| 781 |
Tetrabromobisphenol A bis(2-hydroxyethyl) ether
|
-
Tetrabromobisphenol A bis(2-hydroxyethyl) ether, CAS-RN: 4162-45-2, DTXSID4038922
|
None
|
| 782 |
1-Ethyl-1-nitrosourea
|
-
1-Ethyl-1-nitrosourea, CAS-RN: 759-73-9, DTXSID8020593
|
504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level
|
| 783 |
Cyclizine
|
-
Cyclizine, CAS-RN: 82-92-8, DTXSID4022864
|
504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level
|
| 784 |
UV-B and UV-C
|
|
550: Increased LMNA gene mutation leading to heart failure
|
| 785 |
Camptothecin
|
|
550: Increased LMNA gene mutation leading to heart failure
|
| 786 |
Carbamate pesticides
|
|
551: Increased Muscarinic M2 Receptor leading to Arrhythmia
|
| 787 |
Cholinergic drugs
|
|
551: Increased Muscarinic M2 Receptor leading to Arrhythmia
|
| 788 |
Halogenated Hydrocarbons
|
|
519: Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality
|
| 789 |
terfenadine
|
|
519: Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality
|
| 790 |
Flecainide
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 791 |
Bupivacaine
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 792 |
Tetracaine
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 793 |
Saxitoxin
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 794 |
Tetrodotoxin derivatives
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 795 |
Isoproterenol
|
|
2 AOPs
|
| 796 |
Epinephrine
|
|
554: β-adrenergic receptor agonists leading to arrhythmias.
|
| 797 |
Norepinephrine
|
|
554: β-adrenergic receptor agonists leading to arrhythmias.
|
| 798 |
Theophylline
|
|
554: β-adrenergic receptor agonists leading to arrhythmias.
|
| 799 |
Milrinone
|
|
2 AOPs
|
| 800 |
Sotalol
|
|
555: Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure
|
| 801 |
Dofetilide
|
|
555: Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure
|
| 802 |
ziprasidone
|
|
555: Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure
|
| 803 |
E-4031
|
|
2 AOPs
|